Strengthening the Interdisciplinary and Inter Sectoral Collaboration in Stroke Rehabilitation Through Application of FIM
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04564820 |
Recruitment Status :
Completed
First Posted : September 25, 2020
Last Update Posted : February 8, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Stroke Rehabilitation |
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 20 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 4 Months |
Official Title: | Application of the Functional Independence Measure® (FIM) With the Aim of Strengthening the Interdisciplinary and Inter Sectoral Collaboration in Stroke Rehabilitation - a Mixed Methods Multicenter Study |
Actual Study Start Date : | January 25, 2021 |
Actual Primary Completion Date : | November 1, 2021 |
Actual Study Completion Date : | January 15, 2022 |
- Functional Independence Measure® (FIM) [ Time Frame: Admittance to hospital to discharge from a facility in the municipality, approx. 4 months. ]FIM® measures disability by the amount of assistance needed during daily activities. FIM consists of 18 items, 13 in the motor and 5 in the cognitive domain. The scale ranges from 18-126.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Quantitative Study Participants:
Inclusion Criteria:
- Diagnosed with stroke (i61 and i63).
- Hospitalized for stroke rehabilitation in Bispebjerg Hospital.
- Hospitalized in Regional Beds (given to patients with a brain damage of moderate to severe character who receives intensive rehabilitation) within 1 week of arrival at the hospital.
- Living in the Municipality of Copenhagen.
- Consenting to participate.
Exclusion Criteria:
- Discharged to other facility than Neurorehabilitering Copenhagen.
- Unable to participate in neuro-rehabilitation in more than one week continuously due to e.g. infection.
Qualitative study participants:
Interview Study Participants:
Inclusion Criteria:
- Interdisciplinary staff at Bispebjerg Hospital Neurological Rehabilitation Department and Neurorehabilitering Copenhagen.
- Participant in the project group experimenting with the FIM
- Consenting to participate.
Participant observation:
Inclusion Criteria:
- Interdisciplinary staff at Bispebjerg Hospital Neurological Rehabilitation Department and Neurorehabilitering Copenhagen.
- Participant in FIM team meetings.
- Consenting to participate.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04564820
Denmark | |
Neurorehabilitering Copenhagen | |
Copenhagen, Hellerup, Denmark, 2900 | |
Bispebjerg Hospital | |
Copenhagen, København NV, Denmark, 2400 |
Principal Investigator: | Irene Conradsen, Master | Neurorehabilitering Copenhagen |
Responsible Party: | Jon Damsager Lauesen, Consultant, Neurorehabilitering - Kbh, City of Copenhagen |
ClinicalTrials.gov Identifier: | NCT04564820 |
Other Study ID Numbers: |
20-4000 |
First Posted: | September 25, 2020 Key Record Dates |
Last Update Posted: | February 8, 2022 |
Last Verified: | January 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Stroke Rehabilitation Interdisciplinary Functional Independence Measure FIM |
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |